James Kihara - Nov 17, 2021 Form 4 Insider Report for ACADIA PHARMACEUTICALS INC (ACAD)

Role
Principal Accounting Officer
Signature
/s/ Austin D. Kim, Attorney-in-Fact
Stock symbol
ACAD
Transactions as of
Nov 17, 2021
Transactions value $
$0
Form type
4
Date filed
11/19/2021, 05:36 PM
Next filing
Feb 25, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACAD Restricted Stock Units Award $0 +15.9K $0.00 15.9K Nov 17, 2021 Common Stock 15.9K Direct F1, F2
transaction ACAD Restricted Stock Units Award $0 +15.9K $0.00 15.9K Nov 17, 2021 Common Stock 15.9K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock.
F2 The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date.
F3 The restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. In addition, these restricted stock units may vest earlier upon the Issuer's common stock achieving a specified price per share over a specified trading period.